TY - JOUR
T1 - Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus
AU - Van Den Oord, Stijn C.H.
AU - Akkus, Zeynettin
AU - Renaud, Guillaume
AU - Bosch, Johan G.
AU - Van Der Steen, Antonius F.W.
AU - Sijbrands, Eric J.G.
AU - Schinkel, Arend F.L.
N1 - Publisher Copyright:
©The Author 2014.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Aims Patients with diabetes mellitus (DM) are at severely increased risk of developing atherosclerosis. Intraplaque neovascularization (IPN) and plaque ulceration are markers of the vulnerable plaque, which is at an increased risk of rupture and maylead to cardiovascular events. The aim of this study wasto assess the prevalence of subclinical carotid atherosclerosis, intraplaque neovascularization (IPN), and plaque ulceration in asymptomatic patients with DM. Methods and results A total of 51 asymptomatic patients with DM underwent standard carotid ultrasound in conjunction with contrastenhanced ultrasound (CEUS) to assess the prevalence of subclinical atherosclerosis, IPN, and plaque ulceration. Subclinical atherosclerosis was defined as the presence of atherosclerotic plaque, according to the Mannheim consensus. Semi-automated quantification software was used to assess IPN in suitable plaques. Plaque ulceration was defined as a disruption of the plaque-lumen border of ≥1 × 1 mm. A total of 408 carotid segments in 102 carotid arteries were investigated. Forty-six (90%) patients had subclinical atherosclerotic plaques, with a median plaque thickness of 2.4 mm (inter-quartile range 1.9-3.0). CEUS revealed IPN in 88% of the patients. In 10 carotid segments (8%), the plaque had an ulcerated surface. The presence of IPN could not be predicted by the presence of clinical characteristics including complications of DM (P. 0.05). Conclusion Patients with DM have a high prevalence (90%) of subclinical carotid atherosclerosis. Severe IPN and plaque ulceration, which are markers of the vulnerable plaque type, were detected in, respectively, 13 and 9% of these patients. Published on behalf of the European Society of Cardiology. All rights reserved.
AB - Aims Patients with diabetes mellitus (DM) are at severely increased risk of developing atherosclerosis. Intraplaque neovascularization (IPN) and plaque ulceration are markers of the vulnerable plaque, which is at an increased risk of rupture and maylead to cardiovascular events. The aim of this study wasto assess the prevalence of subclinical carotid atherosclerosis, intraplaque neovascularization (IPN), and plaque ulceration in asymptomatic patients with DM. Methods and results A total of 51 asymptomatic patients with DM underwent standard carotid ultrasound in conjunction with contrastenhanced ultrasound (CEUS) to assess the prevalence of subclinical atherosclerosis, IPN, and plaque ulceration. Subclinical atherosclerosis was defined as the presence of atherosclerotic plaque, according to the Mannheim consensus. Semi-automated quantification software was used to assess IPN in suitable plaques. Plaque ulceration was defined as a disruption of the plaque-lumen border of ≥1 × 1 mm. A total of 408 carotid segments in 102 carotid arteries were investigated. Forty-six (90%) patients had subclinical atherosclerotic plaques, with a median plaque thickness of 2.4 mm (inter-quartile range 1.9-3.0). CEUS revealed IPN in 88% of the patients. In 10 carotid segments (8%), the plaque had an ulcerated surface. The presence of IPN could not be predicted by the presence of clinical characteristics including complications of DM (P. 0.05). Conclusion Patients with DM have a high prevalence (90%) of subclinical carotid atherosclerosis. Severe IPN and plaque ulceration, which are markers of the vulnerable plaque type, were detected in, respectively, 13 and 9% of these patients. Published on behalf of the European Society of Cardiology. All rights reserved.
KW - Atherosclerosis
KW - Carotid ultrasound
KW - Contrast-enhanced ultrasound
KW - Diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=84933558187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933558187&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jeu127
DO - 10.1093/ehjci/jeu127
M3 - Article
C2 - 24972806
AN - SCOPUS:84933558187
SN - 2047-2404
VL - 15
SP - 1213
EP - 1218
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
IS - 11
ER -